All Stories

  1. A vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized mice
  2. Kaposi’s sarcoma-associated herpesvirus (KSHV) gB dictates a low-pH endocytotic entry pathway as revealed by a dual-fluorescent virus system and a rhesus monkey rhadinovirus expressing KSHV gB
  3. Increased human herpesvirus-8 neutralizing response during remission from Kaposi’s sarcoma
  4. Structures of the Foamy virus fusion protein reveal an unexpected link with the F protein of paramyxo- and pneumoviruses
  5. Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera
  6. Receptor-recognition and antiviral mechanisms of retrovirus-derived human proteins
  7. Structures of the Foamy virus fusion protein reveal an unexpected link with the F protein of paramyxo- and pneumoviruses
  8. Kaposi’s sarcoma-associated herpesvirus glycoprotein K8.1 is critical for infection in a cell-specific manner and functions at the attachment step on keratinocytes
  9. Tim-1 and Tim-4 mediate entry of the human Kaposi’s sarcoma-associated herpesvirus and the related rhesus monkey rhadinovirus
  10. Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidics
  11. Seroepidemiology of the Seasonal Human Coronaviruses NL63, 229E, OC43 and HKU1 in France
  12. Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021
  13. Neutralization of zoonotic retroviruses by human antibodies: Genotype-specific epitopes within the receptor-binding domain from simian foamy virus
  14. The crystal structure of a simian Foamy Virus receptor binding domain provides clues about entry into host cells
  15. Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workers
  16. Neutralization of zoonotic retroviruses by human antibodies: genotype-specific epitopes within the receptor-binding domain from simian foamy virus
  17. The crystal structure of a simian Foamy Virus receptor binding domain provides clues about entry into host cells
  18. The crystal structure of a simian Foamy Virus receptor binding domain provides clues about entry into host cells
  19. Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
  20. Antibodies Targeting KSHV gH/gL Reveal Distinct Neutralization Mechanisms
  21. Human herpesvirus 8 molecular mimicry of ephrin ligands facilitates cell entry and triggers EphA2 signaling
  22. Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection
  23. In Vitro Viral Evolution Identifies a Critical Residue in the Alphaherpesvirus Fusion Glycoprotein B Ectodomain That Controls gH/gL-Independent Entry
  24. Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020
  25. Human herpesvirus 8 molecular mimicry of ephrin ligands facilitates cell entry and triggers EphA2 signaling
  26. Serological reconstruction of COVID-19 epidemics through analysis of antibody kinetics to SARS-CoV-2 proteins
  27. Correction: Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV
  28. Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study
  29. Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus
  30. A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
  31. The prefusion structure of herpes simplex virus glycoprotein B
  32. Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV
  33. Serological signatures of SARS-CoV-2 infection: Implications for antibody-based diagnostics
  34. Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus
  35. X-ray Structures of the Post-fusion 6-Helix Bundle of the Human Syncytins and their Functional Implications
  36. Common characteristics and unique features: A comparison of the fusion machinery of the alphaherpesviruses Pseudorabies virus and Herpes simplex virus
  37. A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion
  38. The Therapeutic Antibody LM609 Selectively Inhibits Ligand Binding to Human αVβ3 Integrin via Steric Hindrance
  39. Structure-Function Dissection of Pseudorabies Virus Glycoprotein B Fusion Loops
  40. Stable Drosophila Cell Lines: An Alternative Approach to Exogenous Protein Expression
  41. Functional Characterization of Glycoprotein H Chimeras Composed of Conserved Domains of the Pseudorabies Virus and Herpes Simplex Virus 1 Homologs
  42. A replication defect of pseudorabies virus induced by targeted α-helix distortion in the syntaxin-like bundle of glycoprotein H (V275P) is corrected by an adjacent compensatory mutation (V271A)
  43. Structure-Based Functional Analyses of Domains II and III of Pseudorabies Virus Glycoprotein H
  44. The Highly Conserved Proline at Position 438 in Pseudorabies Virus gH Is Important for Regulation of Membrane Fusion
  45. Structure-Based Mutational Analysis of the Highly Conserved Domain IV of Glycoprotein H of Pseudorabies Virus
  46. Virus entry: old viruses, new receptors
  47. Class III Viral Membrane Fusion Proteins
  48. Structure of a core fragment of glycoprotein H from pseudorabies virus in complex with antibody
  49. Efficient method for production of high yields of Fab fragments in Drosophila S2 cells
  50. Class III viral membrane fusion proteins
  51. Pseudorabies virus glycoprotein B can be used to carry foot and mouth disease antigens in DNA vaccination of pigs
  52. Structure of a trimeric variant of the Epstein–Barr virus glycoprotein B
  53. Analysis of Epstein-Barr Virus Glycoprotein B Functional Domains via Linker Insertion Mutagenesis
  54. Characterization of EBV gB indicates properties of both class I and class II viral fusion proteins
  55. Hydrophobic Residues That Form Putative Fusion Loops of Epstein-Barr Virus Glycoprotein B Are Critical for Fusion Activity
  56. Use of NMR to study serpin function
  57. Insight into Residues Critical for Antithrombin Function from Analysis of an Expanded Database of Sequences That Includes Frog, Turtle, and Ostrich Antithrombins
  58. Structural similarity of the covalent complexes formed between the serpin plasminogen activator inhibitor‐1 and the arginine‐specific proteinases trypsin, LMW u‐PA, HMW u‐PA, and t‐PA: Use of site‐specific fluorescent probes of local environment
  59. Formation of Insoluble Oligomers Correlates with ST6Gal I Stable Localization in the Golgi